# Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance.

> **NCT07208214** · NA · NOT_YET_RECRUITING · sponsor: **London North West Healthcare NHS Trust** · enrollment: 242 (estimated)

## Conditions studied

- IBD

## Interventions

- **DIAGNOSTIC_TEST:** TXI

## Key facts

- **NCT ID:** NCT07208214
- **Lead sponsor:** London North West Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 242 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07208214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07208214, "Texture and Colour Enhancement Imaging (TXI) Versus Dye Chromoendoscopy for Dysplasia Detection in IBD Surveillance.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07208214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*